EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
作者：
Verma, J. [1 ]
Verma, D. [1 ]
Maria, A. [1 ]
机构：
[1] VRB Analyt Pvt Ltd, Thana, MH, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN154
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Xiao Zhang
    Zhengyang Yang
    Yongbo An
    Yishan Liu
    Qi Wei
    Fengming Xu
    Hongwei Yao
    Zhongtao Zhang
    World Journal of Surgical Oncology, 20
  • [22] Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Zhang, Xiao
    Yang, Zhengyang
    An, Yongbo
    Liu, Yishan
    Wei, Qi
    Xu, Fengming
    Yao, Hongwei
    Zhang, Zhongtao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [23] Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Wen, Wen
    Zhang, Yong
    Zhang, Hua
    Chen, Yingshuang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 969 - 978
  • [24] Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Wen Wen
    Yong Zhang
    Hua Zhang
    Yingshuang Chen
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 969 - 978
  • [25] Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis
    Huang, Shibo
    Huang, Yanping
    Li, Chunyan
    Liang, Yiwen
    Huang, Miaoyan
    Luo, Raoshan
    Liang, Weiming
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [26] PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis
    Khan, Muhammad
    Du, Kunpeng
    Ai, Meiling
    Wang, Baiyao
    Lin, Jie
    Ren, Anbang
    Chen, Chengcong
    Huang, Zhong
    Qiu, Wenze
    Yuan, Yawei
    Tian, Yunhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review
    Dai, Yun
    Muaibati, Munawaer
    Xie, Weiming
    Abasi, Abuduyilimu
    Li, Kexin
    Tong, Qing
    Zhang, Tao
    Meng, Yifan
    Zhuang, Liang
    Huang, Xiaoyuan
    CANCER INVESTIGATION, 2022, 40 (03) : 293 - 309
  • [28] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis
    Song, Dandan
    Hou, Shufu
    Ma, Ning
    Yan, Bing
    Gao, Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis
    Yang, Yao
    Chen, Dongbo
    Zhao, Bigeng
    Ren, Liying
    Huang, Rui
    Feng, Bo
    Chen, Hongsong
    CANCER MEDICINE, 2023, 12 (08): : 9282 - 9292
  • [30] Efficacy and safety of PD-1/PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis
    Zhang, Meilin
    Song, Jian
    Yang, Hongguang
    Jin, Feng
    Zheng, Ang
    ACTA ONCOLOGICA, 2022, 61 (09) : 1105 - 1115
12345